Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Biopharm Startup Tff Pharmaceuticals Raises $14m For Breakthrough Dry Powder Inhalation Platform

by prnewswire.com posted 6months ago 59 views
AUSTIN, Texas, April 3, 2018 /PRNewswire/ -- TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions, announced it has closed an offering of Series A preferred...